[HTML][HTML] Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair

K Salata, M Syed, MA Hussain, R Eikelboom… - Journal of vascular …, 2018 - Elsevier
Objective The objective of this study was to summarize the literature regarding the effects of
renin-angiotensin system blockade (RASB) using angiotensin-converting enzyme inhibitors …

Systematic Review Examining the Association of Angiotensin Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Prescription with Abdominal Aortic …

K Tian, S Thanigaimani, K Gibson… - European Journal of …, 2024 - Elsevier
Objective Whether angiotensin II blockade is an effective medical treatment for abdominal
aortic aneurysms (AAAs) has not been established. This systematic review and meta …

Renin‐Angiotensin‐Aldosterone System Inhibitors Are Associated With Favorable Outcomes Compared to Beta Blockers in Reducing Mortality Following Abdominal …

N Elsayed, AC Gaffey, A Abou‐Zamzam… - Journal of the …, 2023 - Am Heart Assoc
Background The best medical therapy to control hypertension following abdominal aortic
aneurysm repair is yet to be determined. We therefore examined whether treatment with …

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study

KE Kristensen, C Torp-Pedersen… - … , and vascular biology, 2015 - Am Heart Assoc
Objective—The renin–angiotensin system is thought to play a pivotal role in the
pathogenesis of abdominal aortic aneurysms (AAAs). However, effects of angiotensin …

Management of modifiable vascular risk factors improves late survival following abdominal aortic aneurysm repair: a systematic review and meta-analysis

M Khashram, JA Williman, PN Hider, GT Jones… - Annals Of Vascular …, 2017 - Elsevier
Background The main determinants of survival following abdominal aortic aneurysm (AAA)
repair are preexisting risk factors rather than the method of repair chosen. The main aim of …

Current theories and clinical trial evidence for limiting human abdominal aortic aneurysm growth

J Yu, S Liu, J Huang, W Wang - Current drug targets, 2018 - ingentaconnect.com
Background: Abdominal aortic aneurysm (AAA) refers to localized dilation of abdominal
aorta. AAA is largely asymptomatic, but aneurysmal rupture results in a high mortality rate …

[HTML][HTML] Effect of antifibrinolytic therapy with tranexamic acid on abdominal aortic aneurysm shrinkage after endovascular repair

A Aoki, T Suezawa, S Yamamoto, K Sangawa… - Journal of vascular …, 2014 - Elsevier
Objective The long-term outcomes of endovascular abdominal aortic aneurysm repair
(EVAR) remain to be determined, but patients with aneurysm shrinkage after EVAR appear …

[HTML][HTML] Reduction of in-hospital mortality among California hospitals meeting Leapfrog evidence-based standards for abdominal aortic aneurysm repair

BS Brooke, BA Perler, F Dominici, MA Makary… - Journal of vascular …, 2008 - Elsevier
BACKGROUND: The Leapfrog Group established evidence-based standards for abdominal
aortic aneurysm (AAA) repair, including targets for case volume and perioperative β-blocker …

[PDF][PDF] Renin-angiotensin blockade is associated with increased mortality after vascular surgery

CJ Railton, J Wolpin, J Lam-McCulloch… - Canadian Journal of …, 2010 - researchgate.net
Conclusions Examination of 883 cases of AAA repair showed increased mortality associated
with preoperative RAS blockade. A better understanding of perioperative pharmacology and …

Preadmission use of renin–angiotensin blockers and rupture of abdominal aortic aneurysm: a nationwide, population‐based study

H Wemmelund, A Høgh, HH Hundborg… - … and Drug Safety, 2016 - Wiley Online Library
Purpose Rupture of abdominal aortic aneurysms (rAAA) is associated with high mortality.
Use of angiotensin converting enzyme inhibitors (ACE‐inhibitors) and angiotensin receptor …